<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="preprint">
<?all-math-mml yes?>
<?use-mml?>
<?origin ukpmcpa?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">bioRxiv</journal-id>
<journal-title-group>
<journal-title>bioRxiv : the preprint server for biology</journal-title>
</journal-title-group>
<issn pub-type="ppub"/>
</journal-meta>
<article-meta>
<article-id pub-id-type="manuscript">EMS108032</article-id>
<article-id pub-id-type="doi">10.1101/2020.12.08.415018</article-id>
<article-id pub-id-type="archive">PPR250521</article-id>
<article-version article-version-type="publisher-id">1</article-version>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Extended <italic>in vitro</italic> inactivation of SARS-CoV-2 by titanium dioxide surface coating</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Mlcochova</surname>
<given-names>P</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chadha</surname>
<given-names>A</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hesselhoj</surname>
<given-names>T</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fraternali</surname>
<given-names>F</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ramsden</surname>
<given-names>JJ</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gupta</surname>
<given-names>RK</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Cambridge Institute of Therapeutic Immunology &amp; Infectious Disease (CITIID), Cambridge, UK</aff>
<aff id="A2">
<label>2</label>Cambridge Universities Hospitals NHS Trust, Cambridge, UK</aff>
<aff id="A3">
<label>3</label>Invisismart Technologies, UK</aff>
<aff id="A4">
<label>4</label>Randall Centre for Cell and Molecular Biophysics, King’s College London, London, SE1 1UL, UK</aff>
<aff id="A5">
<label>5</label>Development and Homeostasis of the Nervous System Laboratory, The Francis Crick Institute, London NW1 1AT, UK</aff>
<aff id="A6">
<label>6</label>Clore Laboratory, University of Buckingham, Buckingham, UK</aff>
<author-notes>
<corresp id="CR1">
<label>*</label>
<bold>Correspondence:</bold> Ravindra K. Gupta, Cambridge Institute for Therapeutic Immunology and Infectious Diseases, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Puddicombe Way, Cambridge CB2 0AW, <email>Rkg20@cam.ac.uk</email>
</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>11</day>
<month>12</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="preprint">
<day>08</day>
<month>12</month>
<year>2020</year>
</pub-date>
<permissions>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nd/4.0/">
<license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nd/4.0/">CC BY-ND 4.0 International license</ext-link>.</license-p>
</license>
</permissions>
<abstract>
<p id="P1">SARS-CoV-2 transmission occurs via airborne droplets and surface contamination. We show tiles coated with TiO<sub>2</sub> 120 days previously can inactivate SARS-CoV-2 under ambient indoor lighting with 87% reduction in titres at 1h and complete loss by 5h exposure. TiO<sub>2</sub> coatings could be an important tool in containing SARS-CoV-2.</p>
</abstract>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>Background</title>
<p id="P2">Within 10 months, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected 62 million people and has killed over 1.5 million worldwide. Respiratory droplets are believed to be the major vehicle of SARS-COV-2 transmission. Droplets or other body fluids from infected individuals can contaminate surfaces and viable virus has been detected on such surfaces, including surgical masks, for hours, even days depending on different factors including humidity, temperature and type of surface.<sup>
<xref ref-type="bibr" rid="R1">1</xref>,<xref ref-type="bibr" rid="R2">2</xref>,<xref ref-type="bibr" rid="R3">3</xref>
</sup> One therefore infers that any external contamination of PPE may last hours or even days.</p>
<p id="P3">Recently, there has been a further increase in SARS-CoV-2 cases across Europe and the UK, despite severe mitigation measures following the first wave in the first half of 2020. More worryingly, nosocomial transmission within hospitals is being observed despite universal adoption of wearing face masks, regular testing of staff and patients, and social distancing measures. It may well be that contamination of surfaces is now disproportionately contributing to transmission.<sup>
<xref ref-type="bibr" rid="R4">4</xref>,<xref ref-type="bibr" rid="R5">5</xref>
</sup>
</p>
<p id="P4">Traditional forms of decontamination (such as alcohol-based sprays, quaternary ammonium compounds, and sodium hypochlorite and other chlorine-based compounds) require repeated applications. Photocatalytic surfaces, on the other hand, permanently oxidize, inactivate and destroy microorganisms under normal ambient lighting conditions.<sup>
<xref ref-type="bibr" rid="R6">6</xref>
</sup> A recent hospital study of titanium dioxide-coated surfaces demonstrated progressive lowering of the bacterial bioburden.<sup>
<xref ref-type="bibr" rid="R7">7</xref>
</sup> Moreover, the radicals are not considered to induce antimicrobial resistance.<sup>
<xref ref-type="bibr" rid="R8">8</xref>
</sup> TiO<sub>2</sub> is especially attractive because it is considered nontoxic to humans: titanium, coated with its oxide, is the most widely used material for implants.<sup>
<xref ref-type="bibr" rid="R9">9</xref>
</sup> TiO<sub>2</sub> is also exceedingly stable, unlike other photocatalysts such as zinc oxide and tungsten trioxide. Illumination of TiO<sub>2</sub> generates highly oxidizing free radicals that are known to have bactericidal and antiviral action against influenza and rotavirus.<sup>
<xref ref-type="bibr" rid="R10">10</xref>,<xref ref-type="bibr" rid="R11">11</xref>,<xref ref-type="bibr" rid="R12">12</xref>
</sup> SARS-CoV-2 has not hitherto been investigated.</p>
</sec>
<sec id="S2" sec-type="methods | materials">
<title>Methods and materials</title>
<sec id="S3">
<title>Cell lines</title>
<p id="P5">293T and Vero E6 cells were cultured in DMEM complete (DMEM supplemented with 100 U/ml penicillin, 0.1 mg/ml streptomycin, and 10% fetal calf serum). Vero E6 were a gift from Prof. Ian Goodfellow. 293T cells were obtained from ATCC. ACE-2/TMPRSS2-expressing 293T cells were generated as described previously.<sup>
<xref ref-type="bibr" rid="R13">13</xref>
</sup>
</p>
</sec>
<sec id="S4">
<title>Pseudotyped virus</title>
<p id="P6">SARS-CoV-2 Spike pseudotyped HIV-1 luciferase particles were produced by transfection of 293T cells with pCAGGS-SARS-CoV-2 spike, p8.91HIV-1 gag-pol expression and pCSFLW (expressing the firefly luciferase reporter gene with the HIV-1 packaging signal) as previously described.<sup>15</sup> Viral supernatant was collected at 48 and 72 h after transfection, filtered through a 0.45 μm filter and stored at −80 °C. The 50% tissue culture infectious dose (TCID<sub>50</sub>) of SARS-CoV-2 pseudovirus was determined using the Steady-Glo luciferase assay system (Promega).</p>
</sec>
<sec id="S5">
<title>Viral isolate</title>
<p id="P7">Live SARS-CoV-2 (SARS-CoV-2/human/Liverpool/REMRQ0001/2020) used in this study was isolated by Lance Turtle (University of Liverpool), David Matthews and Andrew Davidson (University of Bristol). A SARS-CoV-2 virus stock was produced by infecting Vero E6 cells at MOI 0.01. Culture supernatant was collected 48 h post-infection. The titre of the stock was determined by adding tenfold serial dilutions of virus onto Vero E6 cells. 24 h post-infection cells were fixed, stained for nucleocapsid protein (anti-Nucleocapsid antibody, MA5-36086, ThermoFisher) and %infection determined by flow cytometry. SARS-CoV-2 virus titres were determined as infectious units per ml (IU/ml) as follows: (% infected cells) × (total number of cells) × (dilution factor) / volume of inoculum added to cells.</p>
</sec>
<sec id="S6">
<title>Surfaces and illumination</title>
<p id="P8">Virus stability was evaluated on the following surfaces: sterile untreated Sterilin standard Petri dish; TiO<sub>2</sub>- and TiO<sub>2</sub>–Ag (Ti:Ag atomic ratio 1:0.04)-coated 45 × 45 mm ceramic tiles (Invisi Smart Technologies UK Ltd). The coatings are transparent and colourless and therefore invisible to the human eye. After coating the tiles were stored for 2–4 months before use. Surfaces were exposed (610 lx, ambient laboratory light) for 1 h before the start of each experiment to ensure a steady state of radical generation. The same light was used during virus exposure, during which relative humidity was approximately 65% and temperature 21 °C.</p>
</sec>
</sec>
<sec id="S7">
<title>Surface inoculation and sampling</title>
<sec id="S8">
<title>SARS-CoV-2 spike pseudotyped virus inactivation</title>
<p id="P9">Tile surfaces were inoculated with 10<sup>5</sup> RLU of SARS-CoV-2 spike pseudotyped HIV-1 luciferase virus at time <italic>t</italic> = 0 and illuminated for up to 6 h. At intervals virus was recovered from surfaces with DMEM complete followed by infection of ACE-2/TMPRSS2-expressing 293T cells. Luminescence was measured using Steady-Glo Luciferase assay system (Promega) 48 h post-infection.</p>
</sec>
<sec id="S9">
<title>SARS-CoV-2 live virus inactivation</title>
<p id="P10">6×10<sup>6</sup> IU/ml of SARS-CoV-2 virus was added onto the surface of the tiles at a dosage of 2 μl over 5 × 5 mm. After illuminating for 0–300 min virus was recovered from surfaces with DMEM complete followed by infection of Vero E6 cells. % of infected cells was determined by flow cytometry detecting SARS-CoV-2 nucleocapsid protein 24 h post-infection.</p>
</sec>
<sec id="S10">
<title>Kinetic analysis of inactivation</title>
<p id="P11">The main challenge is that laboratory inactivation experiments are necessarily carried out with large numbers of viruses, with which the inactivating material is brought into contact at the beginning of the experiment, and the decay of the entire virus population is measured.<sup>
<xref ref-type="bibr" rid="R14">14</xref>
</sup> What is of practical interest in the scenario of a coating designed to keep surfaces (e.g., in a hospital) free of viral (and bacterial) bioburden is how quickly an individual virus is inactivated. According to analysis of previously reported results for influenza virus inactivation,<sup>
<xref ref-type="bibr" rid="R11">11</xref>
</sup> the kinetics fit a convective diffusion transport model even in the absence of mechanical agitation, most likely due to almost inevitable thermal gradients.<sup>
<xref ref-type="bibr" rid="R14">14</xref>
</sup> The concentration of survivors is thereby predicted to follow a so-called exponential decrease, and plotting the logarithm of the number of survivors v. time should give a straight line, the slope of which is −<italic>k</italic>, the inactivation rate coefficient. The value of <italic>k</italic> can then be compared with the transport-limited fastest possible rate calculated from the size of the virus.<sup>
<xref ref-type="bibr" rid="R14">14</xref>
</sup>
</p>
</sec>
</sec>
<sec id="S11" sec-type="results">
<title>Results</title>
<p id="P12">After 1 h illumination the pseudotyped viral titre was decreased by four orders of magnitude (<xref ref-type="fig" rid="F1">Figure 1A</xref>). There was no significant difference between the TiO<sub>2</sub> and TiO<sub>2</sub>–Ag coatings. Light alone had no significant effect on viral viability.</p>
<p id="P13">Next, we tested the ability of the coated tiles to inhibit fully infectious live virus. Coated and uncoated surfaces were exposed to SARS-CoV-2. Virus was harvested at the times indicated and used to infect Vero E6 target cells. SARS-CoV-2 was already significantly inactivated on the TiO<sub>2</sub> surfaces after 20 min illumination. After 5 h no detectable active virus remained (<xref ref-type="fig" rid="F1">Figure 1B</xref>). Significantly, SARS-CoV-2 on the untreated surface was still fully infectious at 5 h post-addition of virus. TiO<sub>2</sub>–Ag appeared somewhat less effective than TiO<sub>2</sub> alone, but the difference was not significant.</p>
<p id="P14">Plotting the experimental data (<xref ref-type="fig" rid="F1">Fig. 1B</xref>) as ln(titre) v. time (<xref ref-type="fig" rid="F1">Fig. 1C</xref>) yields a disinfection rate coefficient <italic>k</italic> of (5.2 ± 0.6) × 10<sup>−4</sup> s<sup>−1</sup>, which corresponds to the transport-limited fastest possible rate estimated for SARS-CoV-2 approaching a disinfecting surface in water.<sup>
<xref ref-type="bibr" rid="R14">14</xref>
</sup> Hence we infer that the viruses arriving at the surface from the inoculum are essentially immediately inactivated. From our illumination conditions we estimate the generation rate of radicals as about 10<sup>13</sup> cm<sup>−2</sup> s<sup>−l</sup>,<sup>
<xref ref-type="bibr" rid="R6">6</xref>
</sup> corresponding to about 800 radicals s<sup>−l</sup> over the area occupied by one virus at the surface, By extrapolating the data from the first four points to the assumed detection limit, it can be seen that very likely no detectable virus from the initial inoculum remained soon after 2 h exposure (<xref ref-type="fig" rid="F1">Fig, 1C</xref>).</p>
</sec>
<sec id="S12" sec-type="discussion">
<title>Discussion</title>
<p id="P15">The potent extended anti- SARS-CoV-2 effect of titanium dioxide surface coatings is highly desirable in hospital settings where both patients and staff might be shedding viruses. An important advantage of these surfaces is that they can be activated by ordinary interior light and do not need UV irradiation, which is usually incompatible with simultaneous human presence. The coating has a rough surface with high local curvature that creates an absorption tail into the blue region of the visible spectrum,<sup>
<xref ref-type="bibr" rid="R6">6</xref>
</sup> overlapping the spectral output of ordinary interior lighting. This is sufficient to ensure an adequate rate of radical generation for effectively immediately inactivating viruses and other microorganisms arriving from the air or hand touches. Conversely, a limitation is that if a sudden very large contamination event occurred, particularly one that severely diminished the light reaching the photocatalyst, it might take impracticably long for the contamination to be eliminated. Hence, in that case rough cleaning, even washing with water, should be used to remove the gross contamination.</p>
<p id="P16">The efficacy of the TiO<sub>2</sub> coating under typical hospital lighting makes it a promising candidate for enhancing the protection afforded by facemasks and other PPE, and well as surfaces likely to be contaminated and hence acting as reservoirs for transmitting infection if left untreated.</p>
</sec>
</body>
<back>
<ack id="S13">
<title>Acknowledgement</title>
<p>The authors thank Saba Yussouf (Invisi Smart Technologies) for helpful discussions. We would also like to thank Nigel Temperton for plasmids.</p>
</ack>
<fn-group>
<fn id="FN1" fn-type="conflict">
<p id="P17">
<bold>Conflicts of interest:</bold> TH is chief scientific officer of Invisi Smart Technologies. JJR has consulted for Invisi Smart Technologies. RKG has received a research grant from Invisi Smart Technologies.</p>
</fn>
</fn-group>
<ref-list>
<ref id="R1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chin</surname>
<given-names>AWH</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>JTS</given-names>
</name>
<name>
<surname>Perera</surname>
<given-names>MRA</given-names>
</name>
<name>
<surname>Hui</surname>
<given-names>KPY</given-names>
</name>
<name>
<surname>Yen</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>MCW</given-names>
</name>
<etal/>
</person-group>
<article-title>Stability of SARS-CoV-2 in different environmental conditions</article-title>
<source>Lancet Microbe</source>
<year>2020</year>
<volume>1</volume>
<issue>1</issue>
<fpage>e10</fpage>
</element-citation>
</ref>
<ref id="R2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Doremalen</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bushmaker</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Holbrook</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Gamble</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Williamson</surname>
<given-names>BN</given-names>
</name>
<etal/>
</person-group>
<article-title>Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1</article-title>
<source>N Engl J Med</source>
<year>2020</year>
<volume>382</volume>
<issue>16</issue>
<fpage>1564</fpage>
<lpage>7</lpage>
</element-citation>
</ref>
<ref id="R3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chia</surname>
<given-names>PY</given-names>
</name>
<name>
<surname>Coleman</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>YK</given-names>
</name>
<name>
<surname>Ong</surname>
<given-names>SWX</given-names>
</name>
<name>
<surname>Gum</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lau</surname>
<given-names>SK</given-names>
</name>
<etal/>
</person-group>
<article-title>Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients</article-title>
<source>Nat Commun</source>
<year>2020</year>
<volume>11</volume>
<issue>1</issue>
<fpage>2800</fpage>
</element-citation>
</ref>
<ref id="R4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rivett</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sridhar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sparkes</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Routledge</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>NK</given-names>
</name>
<name>
<surname>Forrest</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission</article-title>
<source>Elife</source>
<year>2020</year>
<fpage>9</fpage>
</element-citation>
</ref>
<ref id="R5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Collier</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Assennato</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Warne</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sithole</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sharrocks</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ritchie</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Point of care nucleic acid testing for SARS-CoV-2 in hospitalized patients: A clinical validation trial and implementation study</article-title>
<source>Cell Rep Med</source>
<year>2020</year>
<comment>100062</comment>
</element-citation>
</ref>
<ref id="R6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramsden</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<article-title>Photocatalytic antimicrobial coatings</article-title>
<source>Nanotechnol Perceptions</source>
<year>2015</year>
<volume>11</volume>
<issue>3</issue>
<fpage>146</fpage>
<lpage>68</lpage>
</element-citation>
</ref>
<ref id="R7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reid</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Whatley</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Spooner</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Nevill</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ramsden</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Dancer</surname>
<given-names>SJ</given-names>
</name>
</person-group>
<article-title>How does a photocatalytic antimicrobial coating affect environmental bioburden in hospitals?</article-title>
<source>Infection Control Hospital Epidemiol</source>
<year>2018</year>
<volume>39</volume>
<issue>4</issue>
<fpage>398</fpage>
<lpage>404</lpage>
</element-citation>
</ref>
<ref id="R8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramsden</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<article-title>Can bacteria develop resistance to photocatalytically generated reactive oxygen species?</article-title>
<source>J Biol Phys Chem</source>
<year>2017</year>
<volume>17</volume>
<issue>2</issue>
<fpage>47</fpage>
<lpage>51</lpage>
</element-citation>
</ref>
<ref id="R9">
<label>9</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Ramsden</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<source>Biomedical Surfaces</source>
<publisher-name>Artech House</publisher-name>
<publisher-loc>Norwood, MA</publisher-loc>
<year>2008</year>
<fpage>12</fpage>
<lpage>5</lpage>
</element-citation>
</ref>
<ref id="R10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonetta</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bonetta</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Motta</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Strini</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Carraro</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Photocatalytic bacterial inactivation by TiO2-coated surfaces</article-title>
<source>AMB Express</source>
<year>2013</year>
<volume>3</volume>
<issue>1</issue>
<fpage>59</fpage>
</element-citation>
</ref>
<ref id="R11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakano</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ishiguro</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kajioka</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fujishima</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sunada</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>
<article-title>Photocatalytic inactivation of influenza virus by titanium dioxide thin film</article-title>
<source>Photochem Photobiol Sci</source>
<year>2012</year>
<volume>11</volume>
<issue>8</issue>
<fpage>1293</fpage>
<lpage>8</lpage>
</element-citation>
</ref>
<ref id="R12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Phan</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Sugihara</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yagyu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Okitsu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Maneekarn</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group>
<article-title>Photocatalytic inactivation of diarrheal viruses by visible-light-catalytic titanium dioxide</article-title>
<source>Clin Lab</source>
<year>2007</year>
<volume>53</volume>
<issue>7–8</issue>
<fpage>413</fpage>
<lpage>21</lpage>
</element-citation>
</ref>
<ref id="R13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mlcochova</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Collier</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ritchie</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Assennato</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Hosmillo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Goel</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group>
<article-title>Combined point of care nucleic acid and antibody testing for SARS-CoV-2 following emergence of D614G Spike Variant</article-title>
<source>Cell Rep Med</source>
<year>2020</year>
<comment>100099</comment>
</element-citation>
</ref>
<ref id="R14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramsden</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<article-title>The kinetics of disinfection by semiconductor photocatalysts</article-title>
<source>J Biol Phys Chem</source>
<year>2020</year>
<volume>20</volume>
<issue>2</issue>
<fpage>60</fpage>
<lpage>7</lpage>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>Effect of InvisiSmart Tio2/Ag and Tio2 tiles on (A) SARS-CoV-2 Spike pseudotype viral infection and (B) SARS-CoV-2 SARS-CoV-2 isolate REMRQ0001/Human/2020/Liverpool. (C) Plot of the data from (B) as ln(%infected cells) v. time. Dashed line, linear regression using the first 4 data points, the slope of which is <italic>k</italic>. The 5 h titre <bold>(zero)</bold> cannot be plotted as its logarithm but extrapolating the regression line to the estimated virus detection limit (1%) suggests that complete inactivation was effectively reached at 2 h 20 min (open circle).</p>
</caption>
<graphic xlink:href="EMS108032-f001"/>
</fig>
</floats-group>
</article>
